How Long Are You Contagious With a Viral Infection?

The contagious window for a viral infection ranges from a few days to several weeks depending on the virus, and in some cases people shed infectious virus before they feel sick at all. For common respiratory viruses like influenza, you are typically most contagious within the first few days of symptoms and taper off within a week. For others, like norovirus, detectable shedding can persist for weeks after you feel better. The picture gets more complicated when you factor in the person’s immune status, age, and vaccination history, all of which shift the timeline in meaningful ways.

Peak Contagiousness in Respiratory Viruses

For the respiratory viruses most people encounter, the highest risk of spreading infection clusters around the first few days of illness. A systematic review of SARS-CoV-2 studies found that viral loads in the upper respiratory tract peaked within the first week of symptoms, often right around symptom onset or between days three and five, then declined steadily.¹ That pattern holds for most mild to moderate COVID infections: contagiousness is highest near symptom onset and drops to near zero after about ten days.²

Influenza follows a broadly similar arc, but the timeline is compressed. Most adults shed influenza virus for about five to seven days after symptoms appear, with the peak in the first two to three days. Young children shed for longer on both ends: they start shedding virus before symptoms appear and continue shedding after symptoms resolve for a longer stretch than adults do.³ This is one reason flu rips through daycare centers and elementary schools so effectively.

RSV, which causes bronchiolitis in infants and cold-like symptoms in older kids and adults, has an average shedding duration of about a week in hospitalized infants, though some shed virus for up to three weeks.⁴ That wide range matters when you are deciding whether a baby is safe to return to group care.

Spreading Virus Before You Know You Are Sick

One of the most frustrating features of viral contagiousness is that it often starts before any symptoms show up. With SARS-CoV-2, researchers in South Korea estimated that roughly 40 to 45 percent of transmission events occurred before the infected person developed symptoms.⁵ When contact tracing and isolation efforts ramped up, the proportion attributed to presymptomatic spread rose even higher, because symptomatic people were being caught and isolated sooner, leaving presymptomatic transmission as the harder-to-stop engine of spread.

Even people who never develop symptoms can shed live virus. Studies of asymptomatic SARS-CoV-2 carriers confirmed that some produced replication-competent virus, though a positive PCR test alone does not prove that, since PCR can detect fragments of genetic material long after the virus is no longer viable.⁶ The practical takeaway is that you cannot fully rely on how you feel to judge whether you are contagious. With flu, the presymptomatic shedding window is usually about a day. With COVID, it can be two days or occasionally more.

Stomach Bugs Linger Longer Than You Think

If you have ever had norovirus, you know the worst of it burns through you in one to three days. What you probably did not know is that the virus keeps showing up in stool for weeks afterward. In a controlled human challenge study, participants shed norovirus for a median of 28 days after being exposed, with a range stretching from 13 to 56 days.⁷ That is not a typo: some people were still shedding virus nearly two months later, long after they felt perfectly fine.

Children tell a similar story. In a study comparing gastroenteritis viruses, norovirus was detected in stool in 70 percent of children at day 28, compared to about half of those with rotavirus and a much smaller fraction of those with adenovirus.⁸ Detection by PCR does not always mean the shed virus is infectious at that point, but it does explain why norovirus outbreaks are notoriously hard to stamp out in cruise ships, nursing homes, and schools. Even after the vomiting stops, meticulous hand hygiene and surface cleaning remain important for weeks.

Rotavirus, the other major childhood stomach virus, tends to clear faster than norovirus but can still be shed for one to two weeks after symptoms resolve. Since the introduction of rotavirus vaccines, severe cases have dropped dramatically in countries with routine childhood immunization, but the virus still circulates and the shedding timeline has not changed for those who get infected.

Herpes Viruses and the Concept of Intermittent Shedding

Not all viral infections have a clean “contagious, then not contagious” arc. Herpes simplex viruses, both oral (HSV-1) and genital (HSV-2), set up permanent residence in nerve cells and reactivate periodically throughout a person’s life. Between outbreaks, the virus can still be shed from skin or mucosal surfaces without any visible sores. This is called subclinical or asymptomatic shedding, and it is the mechanism behind a large proportion of herpes transmission.

For genital HSV-2, shedding is most frequent in the first year after the initial infection, occurring on roughly a quarter of days sampled. That frequency drops over time but never reaches zero: people ten or more years from their first episode still shed virus on about 9 percent of days.⁹ This means that even without symptoms, transmission risk persists indefinitely, though it decreases over the years.

Oral HSV-1 behaves similarly. When researchers tested saliva using sensitive molecular methods, they found HSV-1 DNA on about a third of days sampled across hundreds of patients, with shedding episodes typically lasting one to three days each.¹⁰ Traditional culture methods detected far less, which is partly why the extent of asymptomatic oral shedding was underappreciated for decades. The upshot is that cold sores are not the only time oral herpes is transmissible; the virus quietly shows up in saliva far more often than most people realize.

Viruses That Stay With You for Life

Epstein-Barr virus, the cause of most cases of mono, is another herpesvirus that establishes lifelong latency. After the initial infection resolves, EBV hides in a type of immune cell and periodically reactivates, shedding into saliva. The amount shed by a given person fluctuates wildly over time, varying by several orders of magnitude over months to a year.¹¹ In other words, the same person might shed a huge amount of virus one week and almost none the next. There is no reliable way to predict when those spikes happen, which is why the vast majority of EBV transmission occurs without either party being aware of it.

EBV, HSV, and cytomegalovirus (CMV) all share this strategy of latency followed by sporadic reactivation. They persist because they have evolved sophisticated ways to dodge the immune system, hiding in cells with minimal gene activity and reactivating just enough to produce fresh virus before the immune system clamps down again.¹² For these viruses, asking “how long are you contagious” misses the point. You are intermittently contagious for life, at unpredictable intervals, often without knowing it.

Why Some People Stay Contagious Much Longer

The timelines described above apply to people with reasonably healthy immune systems. When immunity is compromised, the rules change. People with weakened immune systems from conditions like organ transplants, certain cancers, or HIV can shed live, replication-capable virus for dramatically longer periods. A systematic review of prolonged SARS-CoV-2 shedding in immunocompromised patients found that the median duration of culture-positive (meaning genuinely infectious) virus was about 60 days from symptom onset, with the longest case stretching past 200 days.¹³ Compare that to the roughly ten-day window in otherwise healthy people, and the difference is staggering.

This is not just a theoretical concern. Case reports have documented immunocompromised patients continuously shedding SARS-CoV-2 with high viral loads for months, capable of infecting others long after the typical isolation period ends.¹⁴ Severely ill patients, even those with intact immune systems, also shed longer than those with mild infections. For SARS-CoV-2, severe and critical illness extended the contagious window to about 15 days, versus roughly ten for milder cases.²

Age matters too, especially at the younger end. Children tend to shed many respiratory viruses for longer than adults. With SARS-CoV-2, children were found to shed virus in stool for longer than adults, possibly because of differences in the gut’s susceptibility to the virus and because young children are more likely to swallow respiratory secretions or touch contaminated surfaces and then their mouths.¹⁵ The same pattern holds for influenza, where children under six shed virus for longer both before and after symptoms compared to adults.³

Does Vaccination Shorten the Contagious Period?

Vaccination does not make you immune to infection in most cases, but it does appear to shorten the window during which you shed live virus. A longitudinal study of people infected with the SARS-CoV-2 Delta variant found that vaccinated participants shed infectious virus for a median of six days, compared to seven and a half days for the unvaccinated. More strikingly, from day six onward after symptom onset, the odds of still shedding infectious virus were less than half as high in vaccinated individuals.¹⁶ The maximum amount of virus detected was similar regardless of vaccination status, but vaccinated people cleared it faster. That distinction matters for household contacts and workplaces: peak risk may be similar, but the tail end of contagiousness is shorter if you are vaccinated.

A study of Omicron patients echoed these findings, showing that people who were IgG antibody positive, a marker boosted by vaccination, shed virus for about a day less on average than those who were antibody negative. A booster dose was among the strongest protective factors for having a positive antibody response.¹⁷ A day might sound modest, but across millions of infections, even a small reduction in shedding duration meaningfully reduces onward transmission.

How to Tell When You Are No Longer Contagious

This is the question people really want answered, and unfortunately it does not have a neat universal response. For most mild respiratory infections, the traditional guidance of isolating for five days after symptom onset and then wearing a mask for a few more reflects the general trajectory of viral clearance. But individual variation is large. Some people are done shedding by day five; others still carry infectious virus at day ten or beyond.

Symptom resolution alone is an unreliable marker. A study tracking non-hospitalized adults with COVID found that between days six and ten after symptom onset, whether someone still had symptoms had no meaningful association with whether they were still growing live virus in culture.¹⁸ You could feel fine and still be shedding infectious virus, or feel miserable with lingering congestion and be well past your contagious window.

Rapid antigen tests turn out to be a better practical tool. Multiple studies have found strong agreement between a positive antigen test and the ability to grow live virus in culture, which is the gold standard for true contagiousness.¹⁹ When your rapid test turns negative, the odds that you are still shedding viable virus drop considerably. PCR tests, by contrast, can remain positive for weeks or even months after you stop being infectious, because they detect tiny fragments of viral genetic material long after the live virus is gone.⁶ A lingering positive PCR result after a COVID infection almost never means you are still contagious.

One study found that among adults with COVID, the median time from symptom onset to the first negative antigen test was about nine days, while the median time to a negative PCR was beyond 19 days.¹⁸ That ten-day gap illustrates why PCR testing created so much confusion during the pandemic. People testing positive on PCR three weeks out were often told to keep isolating when they were almost certainly no longer infectious.

Antiviral Treatment and Viral Clearance

Starting antiviral medications early in an infection can shorten the contagious period. For SARS-CoV-2, a propensity-matched study of over 500 high-risk patients found that those who received early antiviral treatment cleared the virus faster than untreated individuals.²⁰ The timing mattered: the benefit was tied to starting treatment early in the course of illness, ideally within the first few days. This pattern is consistent with how antivirals work for influenza as well, where drugs like oseltamivir reduce symptom duration and viral shedding most effectively when taken within 48 hours of symptom onset.

For immunocompromised patients who shed virus for weeks or months, antiviral therapy can be especially important, though the evidence is less clear-cut because these patients sometimes develop resistance to the drug during prolonged courses. Healthcare teams managing immunocompromised patients with persistent infections often monitor viral cultures rather than relying on symptom resolution or PCR alone, since the gap between PCR positivity and actual infectiousness can be enormous in this population.²¹

How Long Virus Survives on Surfaces

Contagiousness is not just about what is happening inside your body. The virus you deposit on surfaces can remain viable for hours or days depending on the material. Classic work on influenza showed that both influenza A and B survived for 24 to 48 hours on hard, nonporous surfaces like stainless steel and plastic, but less than eight to twelve hours on cloth and paper.²² The virus could transfer from stainless steel to hands for up to 24 hours but survived on hands for only about five minutes after transfer.

These numbers help explain why certain hygiene measures work. Handwashing is effective not because your hands carry virus for a long time, but because during the brief window the virus is viable on your skin, touching your eyes, nose, or mouth is extremely easy. Hard surfaces in bathrooms and kitchens can remain contaminated well past the point when you assume they are clean. For norovirus, which is notoriously hardy on surfaces, the environmental survival time is even longer, which compounds the problem of extended shedding in stool. Wiping down shared surfaces during and after a household illness is not paranoia; it is a rational response to how long these viruses persist outside the body.

Why “Contagious Period” Is Not One Number

If you have been hoping for a simple chart that assigns each virus a clean contagious window, the research makes that difficult. Even for a single virus in a single person, the overlap between shedding duration, infectious dose, and transmission route creates uncertainty. Someone shedding low levels of virus from their respiratory tract on day eight might infect a household member they share a bed with but pose negligible risk to a coworker across a ventilated office. Context shapes risk as much as biology does.

The general contours are consistent enough to be useful, though. For most acute respiratory viruses, peak contagiousness is in the first few days of symptoms, and you are very unlikely to infect anyone after about a week if your immune system is working normally. For gut viruses, the symptomatic phase is short but shedding lasts weeks, so hand hygiene after recovery matters more than most people appreciate. For herpes-family viruses, intermittent shedding is a lifelong phenomenon, and there is no single “contagious period” at all. And for any virus, being immunocompromised can extend contagiousness from days to months, which has real implications for infection control in hospitals and for the people living with those conditions.

1
PubMed Central. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
2
PubMed Central. Duration of SARS-CoV-2 Infectivity: When is it Safe to Discontinue Isolation?
3
PubMed Central. The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua
4
PubMed. Respiratory syncytial virus infections in infants: quantitation and duration of shedding
5
PubMed Central. Proportion of Pre-Symptomatic Transmission Events Associated with COVID-19 in South Korea
6
PubMed Central. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
7
PubMed Central. Norwalk virus shedding after experimental human infection
8
PubMed Central. Significantly Longer Shedding of Norovirus Compared to Rotavirus and Adenovirus in Children with Acute Gastroenteritis
9
PubMed Central. Persistent Genital Herpes Simplex Virus-2 Shedding Years Following the First Clinical Episode
10
PubMed. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity
11
PubMed Central. The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output
12
PubMed Central. Triple Latency as a Driver of Chronic Inflammation: An Integrative View of HSV, EBV, and CMV Persistence in Immunocompetent Hosts
13
PubMed Central. A Systematic Review of Prolonged SARS‐CoV‐2 Shedding in Immunocompromised Persons
14
PubMed Central. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report
15
PubMed Central. Do children need a longer time to shed SARS-CoV-2 in stool than adults?
16
PubMed Central. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
17
PubMed. Effects of vaccination on antibody level and duration of viral shedding in Omicron patients
18
PubMed Central. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study
19
PubMed Central. The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19
20
PubMed. Impact of early antiviral therapy on SARS-CoV-2 clearance time in high-risk COVID-19 subjects: A propensity score matching study
21
PubMed Central. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
22
PubMed. Survival of influenza viruses on environmental surfaces